SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-023467
Filing Date
2018-09-21
Accepted
2018-09-21 16:52:23
Documents
8
Period of Report
2018-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fate-8k_20180920.htm 8-K 42511
2 EX-1.1 fate-ex11_6.htm EX-1.1 386548
3 EX-5.1 fate-ex51_9.htm EX-5.1 13256
4 EX-99.1 fate-ex991_8.htm EX-99.1 10543
5 EX-99.2 fate-ex992_7.htm EX-99.2 10599
6 GRAPHIC gzd51fdgeico000001.jpg GRAPHIC 45879
7 GRAPHIC gj43ldn5dgvp000001.jpg GRAPHIC 25886
8 GRAPHIC g0uga1y5mfps000001.jpg GRAPHIC 45879
  Complete submission text file 0001564590-18-023467.txt   627044
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 181082017
SIC: 2836 Biological Products, (No Diagnostic Substances)